Cargando…
Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212458/ http://dx.doi.org/10.1016/S0016-5085(22)61403-3 |
| _version_ | 1784730598692093952 |
|---|---|
| author | Deepak, Parakkal Kim, Wooseob Paley, Michael Yang, Monica Burdess, Samantha Carvidi, Alexander B. Demissie, Emanuel El-Qunni, Alia A. Haile, Alem Huang, Katherine Escudero, Guadalupe Oliva McMorrow, Lily E. Paez, Diana Pawar, Niti Perantie, Dana C. Schriefer, Rebecca E. Sides, Shannon E. Thapa, Mahima Gergely, Maté Akuse, Sewuese E. Klebert, Michael Mitchell, Lynne Nix, Billy D. Graf, Jonathan Taylor, Kimberly E. Chahin, Salim Ciorba, Matthew A. Katz, Patricia Matloubian, Mehrdad O'Halloran, Jane A. Presti, Rachel M. Wu, Gregory F. Gensler, Lianne S. Nakamura, Mary C. Ellebedy, Ali H. Kim, Alfred H. |
| author_facet | Deepak, Parakkal Kim, Wooseob Paley, Michael Yang, Monica Burdess, Samantha Carvidi, Alexander B. Demissie, Emanuel El-Qunni, Alia A. Haile, Alem Huang, Katherine Escudero, Guadalupe Oliva McMorrow, Lily E. Paez, Diana Pawar, Niti Perantie, Dana C. Schriefer, Rebecca E. Sides, Shannon E. Thapa, Mahima Gergely, Maté Akuse, Sewuese E. Klebert, Michael Mitchell, Lynne Nix, Billy D. Graf, Jonathan Taylor, Kimberly E. Chahin, Salim Ciorba, Matthew A. Katz, Patricia Matloubian, Mehrdad O'Halloran, Jane A. Presti, Rachel M. Wu, Gregory F. Gensler, Lianne S. Nakamura, Mary C. Ellebedy, Ali H. Kim, Alfred H. |
| author_sort | Deepak, Parakkal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92124582022-06-22 Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES Deepak, Parakkal Kim, Wooseob Paley, Michael Yang, Monica Burdess, Samantha Carvidi, Alexander B. Demissie, Emanuel El-Qunni, Alia A. Haile, Alem Huang, Katherine Escudero, Guadalupe Oliva McMorrow, Lily E. Paez, Diana Pawar, Niti Perantie, Dana C. Schriefer, Rebecca E. Sides, Shannon E. Thapa, Mahima Gergely, Maté Akuse, Sewuese E. Klebert, Michael Mitchell, Lynne Nix, Billy D. Graf, Jonathan Taylor, Kimberly E. Chahin, Salim Ciorba, Matthew A. Katz, Patricia Matloubian, Mehrdad O'Halloran, Jane A. Presti, Rachel M. Wu, Gregory F. Gensler, Lianne S. Nakamura, Mary C. Ellebedy, Ali H. Kim, Alfred H. Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212458/ http://dx.doi.org/10.1016/S0016-5085(22)61403-3 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Deepak, Parakkal Kim, Wooseob Paley, Michael Yang, Monica Burdess, Samantha Carvidi, Alexander B. Demissie, Emanuel El-Qunni, Alia A. Haile, Alem Huang, Katherine Escudero, Guadalupe Oliva McMorrow, Lily E. Paez, Diana Pawar, Niti Perantie, Dana C. Schriefer, Rebecca E. Sides, Shannon E. Thapa, Mahima Gergely, Maté Akuse, Sewuese E. Klebert, Michael Mitchell, Lynne Nix, Billy D. Graf, Jonathan Taylor, Kimberly E. Chahin, Salim Ciorba, Matthew A. Katz, Patricia Matloubian, Mehrdad O'Halloran, Jane A. Presti, Rachel M. Wu, Gregory F. Gensler, Lianne S. Nakamura, Mary C. Ellebedy, Ali H. Kim, Alfred H. Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title | Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title_full | Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title_fullStr | Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title_full_unstemmed | Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title_short | Su1481: IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON ANTIBODY DECAY FOLLOWING MRNA VACCINATION TO SARS-COV-2 IN A PROSPECTIVE COHORT OF PATIENTS WITH CHRONIC INFLAMMATORY DISEASES |
| title_sort | su1481: impact of immunosuppressive therapies on antibody decay following mrna vaccination to sars-cov-2 in a prospective cohort of patients with chronic inflammatory diseases |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212458/ http://dx.doi.org/10.1016/S0016-5085(22)61403-3 |
| work_keys_str_mv | AT deepakparakkal su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT kimwooseob su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT paleymichael su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT yangmonica su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT burdesssamantha su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT carvidialexanderb su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT demissieemanuel su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT elqunnialiaa su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT hailealem su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT huangkatherine su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT escuderoguadalupeoliva su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT mcmorrowlilye su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT paezdiana su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT pawarniti su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT perantiedanac su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT schrieferrebeccae su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT sidesshannone su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT thapamahima su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT gergelymate su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT akusesewuesee su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT klebertmichael su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT mitchelllynne su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT nixbillyd su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT grafjonathan su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT taylorkimberlye su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT chahinsalim su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT ciorbamatthewa su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT katzpatricia su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT matloubianmehrdad su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT ohalloranjanea su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT prestirachelm su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT wugregoryf su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT genslerliannes su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT nakamuramaryc su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT ellebedyalih su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases AT kimalfredh su1481impactofimmunosuppressivetherapiesonantibodydecayfollowingmrnavaccinationtosarscov2inaprospectivecohortofpatientswithchronicinflammatorydiseases |